FDA — authorised 28 September 2006
- Application: NDA050786
- Marketing authorisation holder: LABS JUVISE
- Status: supplemented
FDA authorised Pylera on 28 September 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 28 September 2006; FDA has authorised it.
LABS JUVISE holds the US marketing authorisation.